Catalyst Event
Natera Inc (NTRA) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
5/28/2026, 12:00:00 AM
Announced the initiation of patient enrollment for the SIGNAL-ER 101 study to evaluate Signatera MRD-guided treatment de-escalation in early-stage breast cancer on May 28, 2026.
Korean Translation
2026년 5월 28일, 초기 단계 유방암 환자를 대상으로 Signatera MRD 유도 치료 완화를 평가하기 위한 SIGNAL-ER 101 연구의 환자 등록 시작을 발표함.
Related Recent Events
Cisco Systems Inc (CSCO) · Earnings Release
Cisco's Q4 and full fiscal year 2026 earnings release scheduled for August 12, 2026, is assigned high importance due to an estimated price impact of over 10%, scheduled.
8/12/2026, 12:00:00 AM
Gilead Sciences Inc (GILD) · Earnings Release
Gilead's Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The Q2 2026 earnings release for Rocket Lab is set for August 6, 2026, scheduled.
8/6/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q2 2026 earnings release scheduled for August 4, 2026. Analysts project an EPS of $1.55 estimated. Medium importance reflects typical volatility around earnings releases.
8/4/2026, 12:00:00 AM
Monolithic Power Systems Inc (MPWR) · Earnings Release
Monolithic Power Systems Q2 2026 earnings release on 2026-07-30 with analysts forecast of $5.85 EPS forecasted. High importance expected due to historical price volatility during earnings expected.
7/30/2026, 12:00:00 AM
QUALCOMM Inc. (QCOM) · Earnings Release
Qualcomm is expected to release its fiscal Q3 2026 earnings results on July 29, 2026, expected.
7/29/2026, 12:00:00 AM